Завершено
Фаза III
Россия
Allovectin-7®; Dacarbazine (DTIC); Temozolomide (TMZ) · Vical
A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Treatment With 2 mg Intralesional Allovectin-7® Compared to Dacarbazine (DTIC) or Temozolomide (TMZ) in Subjects With Recurrent Metastatic Melanoma